We previously showed that GFI1B deficiency is associated with inferior prognosis in MDS/AML patients and significantly increases LSCs number, partially resulting from epigenetic alterations of Gfi1b target genes [15], but additional mechanisms might contribute to this. Here, GFI1B is linked to myelodysplastic syndrome.